chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Influenza, Insomnia, Pyrexia
Clinical narrative: headache; chills; Fatigue; sleepless night; 101.5 degree fever; weak; flu like feeling; This is a spontaneous report from a contactable consumer (patient). A 49-years-old male patient received bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 19May2021 15:00 (at the age of 49-years-old) (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included covid prior vaccination from an unknown date and unknown if ongoing. There were no concomitant medications. Patient previously took first dose of bnt162b2 (Batch/Lot number was not reported) administered in Left arm on28Apr2021 03:00 PM (at the age of 49-years-old) for covid-19 immunisation and patient experienced chills, headache, was lethargic which lasted 24 hours. Patient previously had Covid in late October and also recently had an antibody test that was positive for short term and long term antibodies in Apr2021 prior to the Pfizer vaccines. The second vaccines effects were much greater and patient had headache, chills, fatigue, sleepless night, 101.5 degree fever, weak, flu like feeling, all events on 19May2021, lasted 36 hours. Patient did not receive any treatment for adverse events. The patient had not received any other vaccine within 4 weeks and other medications in two weeks. Patient had not been tested since the vaccination. Patient did not have any known allergies. It was reported that Pfizer needed to study whether or not those who had Covid and still had antibodies need two vaccines. Seems like the guidance was one size fits all and was not make sense. Could it be studied as to whether one dose was adequate for those that have had Covid. Reporter felt worse from the vaccine each time then when he did have Covid. Outcome of all events were recovered on an unspecified date in 2021.   The lot number for the vaccine, [bnt162b2], was not provided and will be requested during follow up.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Herpes zoster, Hyperaesthesia, Inappropriate schedule of product administration, Pain
Clinical narrative: administration date: 26Apr2021, dose number: 1/ administration date: 10May2021, dose number: 2; Rash showed up on face 8 days after dose #2; Body aches began the day after dose #2.; The day after receiving dose #2 of the vaccine Headache began and lasted over a week; shingles; One week after receiving dose #2 skin sensitivity on face began; This is a spontaneous report from a contactable consumer (patient). A 35-year-old non-pregnant female patient received bnt162b2, second single dose via an unspecified route of administration, administered in Arm Left on 10May2021 10:30 (Batch/Lot number was not reported) for covid-19 immunisation at age of 35-year-old. The patient previously received first dose of bnt162b2 26Apr2021 at 10:30 for COVID-19 Immunization on arm Left at age of 35-year-old. The patient's medical history was not reported. Concomitant medications were none. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient didn't receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The day after receiving second dose of the vaccine headache began on 10May2021 and lasted over a week. Body aches began the day after second dose on 11May2021. One week after receiving second dose skin sensitivity on face began in May2021. Rash showed up on face 8 days after second dose in 18May2021. Regulatory Authority visit on 21May2021 confirmed shingles. The events as resulted in emergency room/department or urgent care. The patient received Antiviral medication as treatment. The outcome of event headache was recovered in May2021 (duration: 1 week), outcome of the other events was not recovered.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: administration date: 26Apr2021, dose number: 1/ administration date: 10May2021, dose number: 2; Rash showed up on face 8 days after dose #2; Body aches began the day after dose #2.; The day after receiving dose #2 of the vaccine Headache began and lasted over a week; shingles; One week after receiving dose #2 skin sensitivity on face began; This is a spontaneous report from a contactable consumer (patient). A 35-year-old non-pregnant female patient received bnt162b2, second single dose via an unspecified route of administration, administered in Arm Left on 10May2021 10:30 (Batch/Lot number was not reported) for covid-19 immunisation at age of 35-year-old. The patient previously received first dose of bnt162b2 26Apr2021 at 10:30 for COVID-19 Immunization on arm Left at age of 35-year-old. The patient's medical history was not reported. Concomitant medications were none. The patient didn't receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient didn't receive any other medications within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The day after receiving second dose of the vaccine headache began on 10May2021 and lasted over a week. Body aches began the day after second dose on 11May2021. One week after receiving second dose skin sensitivity on face began in May2021. Rash showed up on face 8 days after second dose in 18May2021. Regulatory Authority visit on 21May2021 confirmed shingles. The events as resulted in emergency room/department or urgent care. The patient received Antiviral medication as treatment. The outcome of event headache was recovered in May2021 (duration: 1 week), outcome of the other events was not recovered.   This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts completed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Lip swelling
Clinical narrative: Upper lip swelling; Upper lip swelling and numbness; This is a spontaneous case received from a contactable other healthcare professional. A 44-year-old non pregnant female patient received first dose of bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number was unknown), via an unspecified route of administration on 21May2021 (age at vaccination 44-year-old) as DOSE 1, SINGLE for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient's medical history included hypertension and supraventricular tachycardia. The patient was allergic to penicillin and sulfa drugs and the patient previously took amoxicillin and experienced allergy. Concomitant medications include CARVEDILOL, LISINOPRIL and ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22May2021, the patient experienced upper lip swelling and numbness. These events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of these events. The outcome of the events was unknown.   No follow-up attempts are possible. Information about lot/batch number cannot be obtained. No further information was expected.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Fatigue, Myalgia, Pyrexia
Clinical narrative: Fever; Chills; Pain in the muscle and joints; Pain in the muscle and joints; Had continued fatigue for the two following weeks; This is a spontaneous report from a contactable consumer. A 34-years-old male patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 05May2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration on an unknown date as dose 1, single for COVID-19 immunisation. On 05May2021, 12 hours after injection of the second dose of the vaccine, the patient experienced fever and chills, along with pain in the muscle and joints. He took paracetamol (TYLENOL) to reduce the fever. The patient had continued fatigue for the two following weeks. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of fever which included treatment with paracetamol (TYLENOL) (self-administered) to reduce the fever. The outcome of the events was recovered on an unspecified date of May2021.  The lot number for the vaccine, [BNT162b2], was not provided and will be requested during follow up.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Decreased appetite, Dyspnoea, Fatigue, Myalgia
Clinical narrative: loss of taste; short of breath; body aches; loss of appetite; Night sweats; burning muscles; tired; This is a spontaneous report from a contactable consumer (patient). A 48-years-old non-pregnant female patient received bnt162b2, (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: unknown) via an unspecified route of administration on 22May2021 at 13:15 (at the age of 48-year-old) in right arm as dose number unknown, single for covid-19 immunisation. The patient medical history included COVID long hauler, ptsd, shoulder surgery in November and COVID-19. Concomitant medication(s) included vitamin d nos (VITAMIN D NOS); vitamin b [vitamin b nos] (VITAMIN B [VITAMIN B NOS]); calcium (CALCIUM); duloxetine (DULOXETINE); alprazolam (XANAX) and multi vit (MANUFACTURER UNKNOWN) taken for unknown indication from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. COVID prior vaccination, the patient was diagnosed with COVID-19. Not tested for COVID post vaccination. On 23May2021 02:00, the patient experienced night sweats, body aches/burning muscles, tired, loss of appetite, short of breath and loss of taste. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment was received for the events. The clinical outcome of the events were not recovered.  Follow-up activities closed. Batch/lot number not available for [Vaccine, BNT162B2].
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Night sweats, Pain
Clinical narrative: loss of taste; short of breath; body aches; loss of appetite; Night sweats; burning muscles; tired; This is a spontaneous report from a contactable consumer (patient). A 48-years-old non-pregnant female patient received bnt162b2, (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: unknown) via an unspecified route of administration on 22May2021 at 13:15 (at the age of 48-year-old) in right arm as dose number unknown, single for covid-19 immunisation. The patient medical history included COVID long hauler, ptsd, shoulder surgery in November and COVID-19. Concomitant medication(s) included vitamin d nos (VITAMIN D NOS); vitamin b [vitamin b nos] (VITAMIN B [VITAMIN B NOS]); calcium (CALCIUM); duloxetine (DULOXETINE); alprazolam (XANAX) and multi vit (MANUFACTURER UNKNOWN) taken for unknown indication from unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. COVID prior vaccination, the patient was diagnosed with COVID-19. Not tested for COVID post vaccination. On 23May2021 02:00, the patient experienced night sweats, body aches/burning muscles, tired, loss of appetite, short of breath and loss of taste. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No treatment was received for the events. The clinical outcome of the events were not recovered.  Follow-up activities closed. Batch/lot number not available for [Vaccine, BNT162B2].
Age: 17.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: tender swollen lymph node in her armpit; This is a spontaneous report from a contactable consumer. This consumer reported for a 17-year-old female patient (Daughter). A 17-year-old old non pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation: solution for injection, Batch/Lot Number: unknown), via unknown route of administration on 10Apr2021 (at the age of 17 years old), DOSE 1 SINGLE for covid-19 immunisation. The patient did not have Known allergies and other medical history. The concomitant medication of the patient was not reported. The patient did not receive other vaccine in four weeks. The patient did not have COVID prior vaccination. The patient experienced a very tender swollen lymph node in her neck (same side as the shot) beginning a day or two after the first vaccine. The patient did not teste for COVID post vaccination. At the time of this report the outcome of the event was unknown.  Information on the lot/batch number had been requested.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Lip swelling, Oropharyngeal pain, Paraesthesia oral
Clinical narrative: Swollen lips; Tingly lips; Scratchy throat; Dizzy; Vomiting; Headache; This is a spontaneous report from a contactable consumer (patient). A 14-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiry date: not reported, at the age of 14-year-old), dose 1 via an unspecified route of administration, administered in left arm on 22May2021 17:15 as dose 1, single for covid-19 immunisation. The patient previously took penicillin and experienced penicillin allergy. Concomitant medication was none. The patient did not receive any other mediations in two weeks of vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22May2021 19:00, the patient experienced swollen lips, tingly lips, scratchy throat, dizzy, vomiting, headache. Therapeutic measures were taken as a result of reported events which included treatment with benadryl and other unspecified over the counter medications (OTC) from an unspecified date in May2021 and unknown if ongoing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The outcome of events was recovering.  The lot number for BNT162b2, was not provided and will be requested during follow up.  No follow-up attempts are possible. No further information is expected.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Swollen lips; Tingly lips; Scratchy throat; Dizzy; Vomiting; Headache; This is a spontaneous report from a contactable consumer (patient). A 14-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiry date: not reported, at the age of 14-year-old), dose 1 via an unspecified route of administration, administered in left arm on 22May2021 17:15 as dose 1, single for covid-19 immunisation. The patient previously took penicillin and experienced penicillin allergy. Concomitant medication was none. The patient did not receive any other mediations in two weeks of vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22May2021 19:00, the patient experienced swollen lips, tingly lips, scratchy throat, dizzy, vomiting, headache. Therapeutic measures were taken as a result of reported events which included treatment with benadryl and other unspecified over the counter medications (OTC) from an unspecified date in May2021 and unknown if ongoing. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The outcome of events was recovering.  The lot number for BNT162b2, was not provided and will be requested during follow up.  No follow-up attempts are possible. No further information is expected.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash developed 2 days after vaccine. rash was on legs only (and NOT at site of injection); This is a spontaneous report from a contactable consumer (patient). A 12-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown, Expiry Date: Not Reported), via an unspecified route of administration in the left arm on 18May2021 at 18:00 (at the age of 12 years) as dose number unknown single for COVID-19 immunisation. The patient was allergic to pecans, walnuts, hazelnuts. The patient had no known concomitant medications. Prior to the vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. The patient did not receive any other medications within two weeks of the vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 20May2021, patient experienced rash which developed 2 days after vaccine, rash was on legs only (and NOT at site of injection). The rash was not clearly associated with vaccine, but patient thought worth reporting, given that patient don't have another explanation for the rash. It resolved after 2 days. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken for the reported events. Outcome of the events were recovered on 22May2021.  Follow-up attempts have been completed and no further information is expected.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Chills, Dyspnoea, Hyperhidrosis, Nausea
Clinical narrative: Fever began early afternoon day after vaccine; Sweats; Shortness of breathe/labored breathing; Tight chest; Chills; Sore arm morning after vaccine; Nausea began in late morning the day after vaccine; This is a spontaneous report from a contactable consumer (patient).   A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot Number: unknown) via an unspecified route of administration in the left arm on 17May2021 at 17:00 (at the age of 34-year-old) as a dose number unknown, single for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD), migraines, allergies, chronic stomach issues/irritable bowel syndrome (IBS) symptoms and possible allergy to latex. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not received any other vaccines within four weeks prior to the vaccination. On 18May2021, the patient experienced sore arm morning after vaccine (Tuesday), nausea began in late morning the day after vaccine (Tuesday), fever began early afternoon day after vaccine (Tuesday at 15:00), chills, sweats, nausea persisted consistently for about 36 hours (through Thurs morning), fever broke but chills and nausea continued for remainder of day (Thursday). Tight chest/labored breathing when laying down to sleep for Tuesday and Thursday nights and still experiencing much quicker shortness of breath. Therapeutic measures were not taken as a result of these events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever was recovered on an unknown date in May2021. The clinical outcome of the events sore arm morning after vaccine, nausea, chills, sweats, tight chest, shortness of breathe/labored breathing was recovering at the time of this report.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Fever began early afternoon day after vaccine; Sweats; Shortness of breathe/labored breathing; Tight chest; Chills; Sore arm morning after vaccine; Nausea began in late morning the day after vaccine; This is a spontaneous report from a contactable consumer (patient).   A 34-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot Number: unknown) via an unspecified route of administration in the left arm on 17May2021 at 17:00 (at the age of 34-year-old) as a dose number unknown, single for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD), migraines, allergies, chronic stomach issues/irritable bowel syndrome (IBS) symptoms and possible allergy to latex. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not received any other vaccines within four weeks prior to the vaccination. On 18May2021, the patient experienced sore arm morning after vaccine (Tuesday), nausea began in late morning the day after vaccine (Tuesday), fever began early afternoon day after vaccine (Tuesday at 15:00), chills, sweats, nausea persisted consistently for about 36 hours (through Thurs morning), fever broke but chills and nausea continued for remainder of day (Thursday). Tight chest/labored breathing when laying down to sleep for Tuesday and Thursday nights and still experiencing much quicker shortness of breath. Therapeutic measures were not taken as a result of these events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event fever was recovered on an unknown date in May2021. The clinical outcome of the events sore arm morning after vaccine, nausea, chills, sweats, tight chest, shortness of breathe/labored breathing was recovering at the time of this report.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Lymphadenopathy, Myalgia
Clinical narrative: Tender left clavicular lymphadenopathy; fatigued (mild)/significant fatigue; sore deltoid/Myalgias (mild); This is a spontaneous report from a contactable other health professional (patient himself). A 51-years-old male patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: ER8737) via an unspecified route of administration in left arm on 08Apr2021 16:30 as dose 1, single (at the age of 51-years-old) for COVID-19 immunization. Patient was not diagnosed with COVID-19, prior to vaccination. Patient had not been tested for COVID-19, since the vaccination. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient medical history included as hypertension. He had no covid prior vaccination. There were no known allergies. The concomitant medications included lisinopril from an unspecified date in 2001 (at a dose of 5mg for 20 years). The patient stated that he had a sore deltoid on Friday (09Apr2021), he was fatigued (mild) and had myalgia (mild) on Sunday (11Apr2021) and he had significant fatigue, myalgia and tender left clavicular lymphadenopathy on Monday (12Apr2021). He did not work on Monday. The symptoms of severe fatigue and myalgia improved by 13Apr2021 and resolved by 14Apr2021. The tender lymphadenopathy persisted until 28Apr2021. He did not receive treatment for adverse events. Patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- ER8735) via an unspecified route of administration in left arm on 30Apr2021 as dose 2, single for COVID-19 immunization. He experienced severe fatigue, myalgia and headache with fever and occasional rigors with recurrence of tender lymphadenopathy of the left clavicular area and tinnitus with the second dose of vaccination. The outcome of events fatigue and sore deltoid/myalgia was resolved on 14Apr2021 and outcome of event tender left clavicular lymphadenopathy was resolved on 28Apr2021.  Follow-up attempts were completed. No further information was expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Gastric disorder, Headache, Herpes zoster
Clinical narrative: Side effect for the 2nd shot: Slight singles; headache for 1 day; tiredness; vomit; nausea; funny stomach; no appetite for the first two days; sleepy; This is a spontaneous report from a non-contactable consumer. This 39-year-old female consumer (patient) reported that.  A 39-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0186), dose 2 via an unspecified route of administration, administered in Arm Left on 21May2021 16:30 as (At the age of 39-years) dose 2, single for covid-19 immunisation. Medical history included Polycystic ovary syndrome from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient was not pregnant at the time of vaccination. No other vaccine in four weeks. No Other medications in two weeks. No Known allergies ware reported. Patient did not test covid post vaccination. It was Unknown if patient had covid prior vaccination. The patient previously took first dose of BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0175), dose 1 via an unspecified route of administration, administered in Left arm on 30Apr2021 06:30 PM as At the age of 39-years dose 1, single for covid-19 immunisation and experienced muscle pain on left arm, tiredness, and extreme period cramps on 1st day. The patient experienced Side effect for the 2nd shot Slight singles, headache for 1 day, tiredness, vomit, nausea, funny stomach, no appetite for the first two days, sleepy on 21May2021 18:45. Patient did not receive any other treatment for events. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Somnolence, Vomiting
Clinical narrative: Side effect for the 2nd shot: Slight singles; headache for 1 day; tiredness; vomit; nausea; funny stomach; no appetite for the first two days; sleepy; This is a spontaneous report from a non-contactable consumer. This 39-year-old female consumer (patient) reported that.  A 39-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0186), dose 2 via an unspecified route of administration, administered in Arm Left on 21May2021 16:30 as (At the age of 39-years) dose 2, single for covid-19 immunisation. Medical history included Polycystic ovary syndrome from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. Patient was not pregnant at the time of vaccination. No other vaccine in four weeks. No Other medications in two weeks. No Known allergies ware reported. Patient did not test covid post vaccination. It was Unknown if patient had covid prior vaccination. The patient previously took first dose of BNT162B2 PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EW0175), dose 1 via an unspecified route of administration, administered in Left arm on 30Apr2021 06:30 PM as At the age of 39-years dose 1, single for covid-19 immunisation and experienced muscle pain on left arm, tiredness, and extreme period cramps on 1st day. The patient experienced Side effect for the 2nd shot Slight singles, headache for 1 day, tiredness, vomit, nausea, funny stomach, no appetite for the first two days, sleepy on 21May2021 18:45. Patient did not receive any other treatment for events. The outcome of events was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Chest pain, Herpes zoster, Pain in extremity, Pruritus
Clinical narrative: Pain and itching on right lower chest, under right arm and radiating into middle back followed by a rash (vesicles with a red base); Pain and itching on right lower chest, under right arm and radiating into middle back followed by a rash (vesicles with a red base); Pain and itching on right lower chest, under right arm and radiating into middle back followed by a rash (vesicles with a red base); Pain and itching on right lower chest, under right arm and radiating into middle back followed by a rash (vesicles with a red base); Pain and itching on right lower chest, under right arm and radiating into middle back followed by a rash (vesicles with a red base); My wife who is a doctor has said is definitely shingles; This is a spontaneous report from a contactable consumer (patient). A 39-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: EW0177, Expiry Date: not reported) via an unspecified route of administration, administered in arm left on 20May2021 at 18:00 (age at vaccination 39-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no known allergies. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: EW0175, Expiry date: not reported) via an unspecified route of administration, administered in arm left on 29Apr2021 as DOSE 1, SINGLE for covid-19 immunisation. Patient did not receive any other vaccines within 4 weeks prior to the COVID. Prior to vaccination, patient had not been diagnosed with COVID-19 prior and had not been tested for COVID-19 since the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. On 21May2021 at 19:00, the patient experienced pain and itching on right lower chest, under right arm and radiating into middle back followed by a rash (vesicles with a red base) that my wife who was a doctor has said is definitely shingles. The patient did not receive treatment for the adverse event. The patient was not hospitalised for the events. The outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Pain and itching on right lower chest, under right arm and radiating into middle back followed by a rash (vesicles with a red base); Pain and itching on right lower chest, under right arm and radiating into middle back followed by a rash (vesicles with a red base); Pain and itching on right lower chest, under right arm and radiating into middle back followed by a rash (vesicles with a red base); Pain and itching on right lower chest, under right arm and radiating into middle back followed by a rash (vesicles with a red base); Pain and itching on right lower chest, under right arm and radiating into middle back followed by a rash (vesicles with a red base); My wife who is a doctor has said is definitely shingles; This is a spontaneous report from a contactable consumer (patient). A 39-years-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: EW0177, Expiry Date: not reported) via an unspecified route of administration, administered in arm left on 20May2021 at 18:00 (age at vaccination 39-years-old) as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had no known allergies. Historical vaccine included first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot number: EW0175, Expiry date: not reported) via an unspecified route of administration, administered in arm left on 29Apr2021 as DOSE 1, SINGLE for covid-19 immunisation. Patient did not receive any other vaccines within 4 weeks prior to the COVID. Prior to vaccination, patient had not been diagnosed with COVID-19 prior and had not been tested for COVID-19 since the vaccination. The patient did not receive any other medications within 2 weeks of vaccination. On 21May2021 at 19:00, the patient experienced pain and itching on right lower chest, under right arm and radiating into middle back followed by a rash (vesicles with a red base) that my wife who was a doctor has said is definitely shingles. The patient did not receive treatment for the adverse event. The patient was not hospitalised for the events. The outcome of events was not recovered.  Follow-up attempts are completed. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Malaise, Pain, Swelling
Clinical narrative: Could not function correctly; Headache; body aches; Chills; swelling pain; This is a spontaneous report from a contactable consumer or other non hcp. A 44-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot number and expiration date was not reported), via an unspecified route of administration in left arm on 19Apr2021 11:30 as dose 1, single for COVID-19 immunization (at the age of 44-year-old). The patient's medical history and concomitant medications were not reported. Family medical history relevant to AE(s) was none. Prior vaccinations within 4 weeks and AE(s) following prior vaccinations was none. Additional vaccines administered on same date of the Pfizer Suspect was none. The patient could not function correctly, headache, body aches, chills and swelling pain on an unspecified date. Event could not function correctly, body aches, swelling, pain was reported as worsened. Patient explained that her headache came and went when she was in pain. Her body aches and was swollen. Pain was all over the body on the right side. Adverse events did not require visit to emergency room and required physician office visit. Patient went to first care where she was given an antibiotic and nerve pain medicine. These were Diclofenac 75 mg, Prednisone 20mg, Valacyclovir 1gm and Gabapentin 300mg as a treatment for events. The outcome of the events was not recovered.  Follow up needed, further information has been requested.  No follow-up attempts are completed; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a Pfizer-sponsored Program Pfizer from a Contactable consumer (patient). A patient of unspecified age and gender received second dose of bnt162b2 (BNT162B2 PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number: UNKNOWN), via an unspecified route of administration on an unspecified date as dose 2, single for COVID-19 immunisation. The medical history and concomitant medications of the patient were not reported. the patient previously received first dose of BNT162B2 (solution for injection) on an unspecified date as single dose for COVID-19 immunisation. The patient reported that the chest and back covering case of Shingles received after the second dose of the Covid Vaccine on an unspecified date. No doubt scaring patient for life. If patient knew that this was Even a Possibility, patient Never would have gotten their vaccine. Patient telling everyone to Avoid their Poison injections. The outcome of the events was reported as unknown.  Information about Lot/Batch number has been requested.
Age: 31.0
Sex: M
Vaccine: COVID19
Symptoms: Migraine, Vaccination site rash
Clinical narrative: Skin rash near injection site; Severe migraines; This is a spontaneous report from a contactable consumer or other non hcp. A 31-years-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EW0178) via an unspecified route of administration in Arm Left on 12May2021 (age at vaccination 31 years old) as single dose for covid-19 immunisation. Medical history included no from an unknown date and unknown if ongoing. The patient did not have known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks and other medications in 2 weeks prior to the COVID vaccine. The patient had historical vaccine of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Batch/Lot Number: EW0175) via an unspecified route of administration in Arm Left on 12May2021 (age at vaccination 31 years old) as single dose for covid-19 immunisation. There were no concomitant medications. Since the vaccination, the patient had not been tested positive for COVID-19. On 14May2021 the patient experienced skin rash near injection site, severe migraines. The patient did not receive any treatment for the adverse events. The clinical outcome of the event was recovering.  No follow-up attempts are needed. No further information is expected.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Chills, Diarrhoea, Fatigue, Myalgia
Clinical narrative: Fatigue; Severe armpit; Edema; Muscle Aches; Chills; Diarrhea; Nausea; Right Arm pain; This is a spontaneous report from a contactable nurse. This 26-year-old female nurse (patient) reported that she (Weight :200 lb, Height :5' 8 in) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL3302), dose 2 via an intramuscular route of administration on 21Jan2021 at 15:45 in right arm (at the age of 26 years-old) as DOSE 2, SINGLE for covid-19 immunisation. Vaccine facility type was reported as hospital. Vaccine was not administered at the facility. Patient's medical history included Covid-19 contracted. Concomitant medications were not reported. Historical vaccine included first dose of BNT162B2, Lot number; EJ1685 via an intramuscular route of administration on 30Dec2020 at 15:45 at right arm (at the age of 26 years-old) for covid-19 immunisation. Adverse event after the first dose was Fatigue, muscle aches, R arm pain, nausea, diarrhea, fever, chills, cough. There were no relevant tests performed. None culture tests were performed. Predisposing factors included Covid-19 contracted in Aug2020. Antipyretic use included XS Tylenol with Ibuprofen orally on 23Jan2021 after vaccination with onset of symptoms. Patient was not admitted in the hospital. On 22Jan2021 at 15:00, patients experienced fatigue, severe armpit, edema, muscle aches, chills, diarhea, nausea, right arm pain. Causal relationship was provided as yes, serious or life threatening events : no. Patient was not deceased. No treatment was required for the events. No AEs required a visit to emergency room or physician's office. The outcome of events was recovered on 24Jan2021.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Oedema, Pain in extremity
Clinical narrative: Fatigue; Severe armpit; Edema; Muscle Aches; Chills; Diarrhea; Nausea; Right Arm pain; This is a spontaneous report from a contactable nurse. This 26-year-old female nurse (patient) reported that she (Weight :200 lb, Height :5' 8 in) received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL3302), dose 2 via an intramuscular route of administration on 21Jan2021 at 15:45 in right arm (at the age of 26 years-old) as DOSE 2, SINGLE for covid-19 immunisation. Vaccine facility type was reported as hospital. Vaccine was not administered at the facility. Patient's medical history included Covid-19 contracted. Concomitant medications were not reported. Historical vaccine included first dose of BNT162B2, Lot number; EJ1685 via an intramuscular route of administration on 30Dec2020 at 15:45 at right arm (at the age of 26 years-old) for covid-19 immunisation. Adverse event after the first dose was Fatigue, muscle aches, R arm pain, nausea, diarrhea, fever, chills, cough. There were no relevant tests performed. None culture tests were performed. Predisposing factors included Covid-19 contracted in Aug2020. Antipyretic use included XS Tylenol with Ibuprofen orally on 23Jan2021 after vaccination with onset of symptoms. Patient was not admitted in the hospital. On 22Jan2021 at 15:00, patients experienced fatigue, severe armpit, edema, muscle aches, chills, diarhea, nausea, right arm pain. Causal relationship was provided as yes, serious or life threatening events : no. Patient was not deceased. No treatment was required for the events. No AEs required a visit to emergency room or physician's office. The outcome of events was recovered on 24Jan2021.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Lymphadenopathy
Clinical narrative: Left side swollen lymph nodes; total of three Shingles on set just started meds; This is a spontaneous report from a contactable other hcp. A 42-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 25May2021 15:00 (at the age of 42 years) (Batch/Lot Number: Ew0168) as DOSE 2, SINGLE for covid-19 immunisation at Pharmacy or Drug Store. The patient was not pregnant at the time of vaccination. Medical history included thyroid, Diabetes Type 2 from an unknown date and unknown if ongoing, drug hypersensitivity from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient had known allergies to Penicillin, Sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 04May2021 17:00 (Batch/Lot Number: Ee0171) as DOSE 1, SINGLE for covid-19 immunisation. 04Jun2021, the patient experienced, Left side swollen lymph nodes total of three Shingles on set just started me. The events resulted in visit to Physician office. The patient received treatment for the events. The clinical outcome of the events was unknown at the time of report.  Follow-up attempts are completed. No further information is expected.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Body temperature, Chills, Diarrhoea, Fatigue
Clinical narrative: diarrhea; felt very weak; felt very tired; got chills; fever 102 degrees on and off for 3 days; This is a spontaneous report from a contactable consumer(patient). A 15-years-old female patient received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0217,Expiry date was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 04Jun2021 01:15 as DOSE 2, SINGLE for covid-19 immunisation,(At the age of vaccination-15 years). Medical history included food allergy for an unspecified date and unknown if ongoing. Concomitant medication(s) included montelukast sodium taken for an unspecified indication, start and stop date were not reported. The patient previously took bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0182,Expiry date was not reported) dose 1 via an unspecified route of administration, administered in left arm on 14May2021 at 1.00PM for covid-19 immunisation, amoxycillin and experienced drug hypersensitivity. On 04Jun2021 20:00 the patient experienced felt very tired, got chills, fever 102 degrees on and off for 3 days, And also on 05Jun2021 the patient experienced diarrhea, felt very weak. The patient underwent lab tests and procedures which included body temperature: 102 dg on 04Jun2021 fever 102 degrees. Patient received no treatment for the event. The patient had not received any other vaccine within 4 weeks. Patient received no treatment for the event. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.  The outcome of the event was recovered.  Follow-Up (02Aug2021): Follow-up attempts are completed. No further information is expected.
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: diarrhea; felt very weak; felt very tired; got chills; fever 102 degrees on and off for 3 days; This is a spontaneous report from a contactable consumer(patient). A 15-years-old female patient received bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0217,Expiry date was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 04Jun2021 01:15 as DOSE 2, SINGLE for covid-19 immunisation,(At the age of vaccination-15 years). Medical history included food allergy for an unspecified date and unknown if ongoing. Concomitant medication(s) included montelukast sodium taken for an unspecified indication, start and stop date were not reported. The patient previously took bnt162b2 (PFIZER COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW0182,Expiry date was not reported) dose 1 via an unspecified route of administration, administered in left arm on 14May2021 at 1.00PM for covid-19 immunisation, amoxycillin and experienced drug hypersensitivity. On 04Jun2021 20:00 the patient experienced felt very tired, got chills, fever 102 degrees on and off for 3 days, And also on 05Jun2021 the patient experienced diarrhea, felt very weak. The patient underwent lab tests and procedures which included body temperature: 102 dg on 04Jun2021 fever 102 degrees. Patient received no treatment for the event. The patient had not received any other vaccine within 4 weeks. Patient received no treatment for the event. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination.  The outcome of the event was recovered.  Follow-Up (02Aug2021): Follow-up attempts are completed. No further information is expected.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation delayed
Clinical narrative: Delayed period 45 days; This is a spontaneous report from a non-contactable consumer (patient). A 28-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number, expiration date was not reported), left arm, on 26May2021, at dose 2, single and dose 1 single (lot number, expiration date was not reported), on an unspecified date; both via an unspecified route of administration (at the age of 28-years-old) for covid-19 immunization from doctor's office/urgent care. Medical history included covid-19. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the covid-19 vaccine. The patient was not tested with covid-19 after the vaccination. The patient experienced delayed period of 45 days on an unspecified date. No treatment was administered for the event. The outcome of the event was recovered on an unspecified date in 2021.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.